Edmond de Rothschild (Monaco)’s Novo Nordisk NVO Stock Holding History

Edmond de Rothschild (Monaco)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.74M	Buy	+83,482	New	+$2.07M	1.5%	14

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Edmond de Rothschild (Monaco)'s NVO Position: Q3 2016 in Review

Edmond de Rothschild (Monaco) opened a new position in Novo Nordisk (NVO) in Q3 2016: 83,482 shares worth $1.74M. The stake represents 1.5% of the portfolio and ranks #14 among its holdings.

511 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

Edmond de Rothschild (Monaco) held 83,482 shares of Novo Nordisk worth $1.74M as of Q3 2016.
Novo Nordisk was a new Edmond de Rothschild (Monaco) position in Q3 2016.
Novo Nordisk made up 1.5% of Edmond de Rothschild (Monaco)'s portfolio in Q3 2016, its #14 holding.
511 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Edmond de Rothschild (Monaco)'s 13F filing for Q3 2016, filed 21 Nov 2016.